LOX-1 Deletion Attenuates Myocardial Fibrosis in the Aged Mice, Particularly Those With Hypertension
Authors:
Open Access
- 12 October 2021
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 8
Abstract
Background: Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) is a transmembrane glycoprotein that mediates uptake of oxidized low-density lipoprotein (ox-LDL) into cells. Previous studies had shown that LOX-1 deletion had a potential to inhibit cardiac fibrosis in mouse models of hypertension and myocardial infarction. Whether LOX-1 deletion also affects cardiac fibrosis associated with aging still remains unknown. The aim of this study was to investigate the effect of LOX-1 deletion on myocardial fibrosis in the aged mice.Methods: C57BL/6 mice and LOX-1 knockout (KO) mice with C57BL/6 background were studied to the age of 60 weeks. Both genotypes of aged mice were exposed to angiotensin II (Ang II) or saline for additional 4 weeks. The mice were then sacrificed, and myocardial fibrosis, reactive oxygen species (ROS) and expression of LOX-1, fibronectin, collagens, p22phox, and gp91phox were measured.Results: LOX-1 deletion markedly reduced Ang II-mediated rise of blood pressure in the aged mice (vs. saline-treated mice). LOX-1 deletion also limited fibrosis and decreased fibronectin and collagen-3 expression in the hearts of aged mice, but not the expression of collagen-1 and collagen-4. LOX-1 deletion also inhibited ROS production and p22phox expression. As the aged mice were exposed to Ang II for 4 weeks (resulting in hypertension), LOX-1 deletion more pronounced inhibiting myocardial fibrosis and ROS production, and decreasing expression of fibronectin, collagen-1, collagen-2, collagen-3, p22phox, and gp91phox.Conclusion: LOX-1 deletion limited fibrosis and ROS production in the hearts of aged mice. This effect was more pronounced in the aged mice with hypertension induced by Ang II infusion.Keywords
Funding Information
- National Natural Science Foundation of China (81370428, 81873459, U1804166)
- Henan Province University Innovation Talents Support Program
This publication has 28 references indexed in Scilit:
- LOX-1 in the maintenance of cytoskeleton and proliferation in senescent cardiac fibroblastsJournal of Molecular and Cellular Cardiology, 2013
- Lectin-like Oxidized Low-density Lipoprotein Receptor-1 (LOX-1) and Cardiac Fibroblast GrowthHypertension, 2012
- Large Impact of Low Concentration Oxidized LDL on Angiogenic Potential of Human Endothelial Cells: A Microarray StudyPLOS ONE, 2012
- Aging and the Renin-Angiotensin SystemHypertension, 2012
- Losartan Attenuates Human Monocyte-derived Dendritic Cell Immune Maturation via Downregulation of Lectin-like Oxidized Low-density Lipoprotein Receptor-1Journal of Cardiovascular Pharmacology, 2012
- Oxidative Stress and Lectin-Like Ox-LDL-Receptor LOX-1 in Atherogenesis and TumorigenesisAntioxidants & Redox Signaling, 2011
- LOX-1 abrogation reduces cardiac hypertrophy and collagen accumulation following chronic ischemia in the mouseGene Therapy, 2011
- LOX-1 and Angiotensin Receptors, and Their InterplayCardiovascular Drugs and Therapy, 2011
- LOX-1-MT1-MMP axis is crucial for RhoA and Rac1 activation induced by oxidized low-density lipoprotein in endothelial cellsCardiovascular Research, 2009
- Modulation of Angiotensin II–Mediated Hypertension and Cardiac Remodeling by Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 DeletionHypertension, 2008